Vancomycin Dosing: From Trough to AUC

Co-produced by SIDPEC and Pro-CE
 
Vancomycin serves as a pivotal drug in the treatment of infectious diseases. In this activity, participants will better understand appropriate utilization of AUC-based dosing, including evidence-based support of usage and implementation strategies. A discussion for and against estimation of AUC values will be had, along with potential guideline changes practitioners may prepare for.
 
Program Faculty: Michael J Rybak, PharmD, MPH, PhD and Jason M. Pogue, PharmD, BCPS AQ-ID

Register Today